During the past decade, Premiere Retina Specialists conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Premiere Retina Specialists" #1 collaborator was "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Premiere Retina Specialists" are "Macular Degeneration" (2 trials) and "Neovascular (Wet) Age-related Macular Degeneration (AMD)" (1 trials). Many other conditions were trialed in "Premiere Retina Specialists" in a lesser frequency.

Most popular intervention types in "Premiere Retina Specialists" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABP 938" (1 trials), "Abicipar Pegol" (1 trials), "Abicipar pegol" (1 trials), "Aflibercept" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Premiere Retina Specialists" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Premiere Retina Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Premiere Retina Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Premiere Retina Specialists, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".